| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |